Go to deals
Healthcare

Advanced Health Limited has completed a partially underwritten non-renounceable rights offer

Advanced Health Limited has raised funds.

Advanced Health owns and operates a network of day hospitals across South Africa. Listed on the Johannesburg Stock Exchange in 2014, it has established itself as a leader in day surgery across the country. Through its subsidiary Presmed Australia, Advanced Health invests in various day hospitals in Australia.

Oaklins’ team in South Africa acted as corporate and designated advisor in this transaction.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Yaron  Zimbler

Yaron Zimbler

Director

Johannesburg, South Africa
Oaklins Grindrod
 Annerie  Britz

Annerie Britz

Senior Associate

Johannesburg, South Africa
Oaklins Grindrod

Related deals

Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.
TMT

Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.

Bigtincan Holdings Limited (ASX:BTH) has raised US$98.6 via a placement and underwritten accelerated non-renounceable entitlement offer.

Learn more
Alice Queen (ASX:AQX) has raised funds via an institutional placement
Other Industries

Alice Queen (ASX:AQX) has raised funds via an institutional placement

Alice Queen Limited (ASX:AQX) has completed a fundraising. The funds will be used to complete the Horn Island Scoping Study, accelerate exploration activities at Horn Island and support working capital. The placement was significantly oversubscribed and strongly supported by a major shareholder, as well as several existing shareholders and new institutional and sophisticated investors.

Learn more
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Healthcare | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Learn more